LUNA trial 2026: Spark Biomedical tests non-pharmacological device for heavy menstrual bleeding
Spark Biomedical launches LUNA Phase II trial evaluating wearable auricular neurostimulation for heavy menstrual bleeding. What the study design reveals.
Photonova Spectra FDA clearance gives GE HealthCare a stronger hand in advanced CT imaging
GE HealthCare’s Photonova Spectra just won FDA clearance. Find out what this means for photon-counting CT, imaging workflows, and hospital adoption.
Can low-dose radiotherapy reshape osteoarthritis care after Siemens Healthineers’ FDA clearance
Siemens Healthineers expands TrueBeam into osteoarthritis care with FDA clearance. Find out how radiotherapy could reshape chronic pain treatment.
Can Heru’s PretestPro replace multiple pretesting devices in one wearable exam?
Heru’s PretestPro completes four ophthalmic pretests in under two minutes on a VR wearable. Explore what this means for clinic workflow and clinical validation. Read more.
What Neuspera’s 12-month iSNM trial data means for the sacral neuromodulation competitive landscape
Neuspera Medical’s 12-month pivotal SNM trial shows 94% responder rates and zero infections. Analysing what this means for the SNM market. Read more.
How Mitria Medical’s nitinol spacer challenges the edge-to-edge repair model for functional mitral regurgitation
Mitria Medical’s Subvalvular Spacer reaches the U.S. under FDA compassionate use. What it means for FMR patients and what clinical evidence still needs to come.
FDA clears compact SPRY TMS system: can Soterix Medical disrupt the depression treatment market?
Soterix Medical wins FDA clearance for SPRY TMS in treatment-resistant major depression. What the clearance means for the neuromodulation market. Read the analysis.
LRS wins FDA clearance to test ThermoSuit cooling device in pivotal ischemic stroke trial
Life Recovery Systems (LRS), a medical device developer headquartered in Alexandria, Louisiana, has received an Investigational Device Exemption (IDE) from the U.S. Food and Drug Administration to advance its ThermoSuit System into a pivotal clinical trial enrolling ischemic stroke patients. The study, which will enroll up to 160 patients across as many as eight hospitals, […]
Lilly’s $3.5bn Pennsylvania site will anchor U.S. manufacturing for next-gen injectables including retatrutide
Eli Lilly and Company has announced a $3.5 billion investment to build a new injectable medicine and device manufacturing facility in Lehigh Valley, Pennsylvania. The site will focus on producing next-generation weight-loss medicines, including the investigational triple hormone receptor agonist retatrutide. Set to become operational by 2031, this is Lilly’s fourth new U.S. manufacturing site […]
Why UVDI’s new V-MIX air disinfection system could reshape HVAC pathogen control
Find out how UVDI’s V-MIX UV-C disinfection system is pushing upper-room air safety beyond hospitals into schools, offices, and airports.